Showing results (41-50 of 259) with videos related to

Sort By:
Pageof 26
Stem Cell Research & Therapy|September 17, 2015
Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatmentSidan Li, Dehui Zou, Changhong Li, et al.
Haematologica|November 12, 2013
Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prognostic valueGang An, Yan Xu, Lihui Shi, et al.
Plos One|January 26, 2012
Targeting p53 via JNK pathway: a novel role of RITA for apoptotic signaling in multiple myelomaManujendra N Saha, Hua Jiang, Yijun Yang, et al.
Oncotarget|October 31, 2015
MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myelomaFei Li, Yan Xu, Shuhui Deng, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 3, 2015
[Clinical analysis of multiple myeloma patients with bone-related extramedullary disease: a longitudinal study on 834 consecutive patients in a single center of China]Shuhui Deng, Yan Xu, Gang An, et al.
Leukemia & Lymphoma|October 22, 2013
miR-29c down-regulation is associated with disease aggressiveness and poor survival in Chinese patients with chronic lymphocytic leukemiaKeshu Zhou, Zhen Yu, Shuhua Yi, et al.
Medicine|June 3, 2020
Long-term remissions of young patients with high-risk follicular lymphoma after first-line autologous stem cell transplantation: Three case reportsRui Lyu, Tingyu Wang, Dehui Zou, et al.
Chinese Journal of Cancer|September 10, 2016
Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myelomaYun Leng, Lugui Qiu, Jian Hou, et al.
International Journal of Hematology|April 22, 2017
SOX11 regulates the pro-apoptosis signal pathway and predicts a favorable prognosis of mantle cell lymphomaWenjuan Yang, Yanying Wang, Zhen Yu, et al.
Annals of Hematology|October 2, 2024
T(11;14) with multiple myeloma: Standard risk survival but slow and poor responseYuntong Liu, Jingyu Xu, Wenqiang Yan, et al.
Pageof 26